| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 89 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 79 |
| 2 | TACROLIMUS OINTMENT 0.1% | 79 |
| 3 | MYCOPHENOLATE MOFETIL | 70 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 70 |
| 5 | PREDNISONE | 66 |
| 6 | RITUXIMAB | 65 |
| 7 | METHYLPREDNISOLONE | 61 |
| 8 | RIVAROXABAN | 45 |
| 9 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BIVALIRUDIN | 8 | 0.0081 |
| 1 | BUTALBITAL AND ACETAMINOPHEN | 4 | 0.0065 |
| 2 | ARGATROBAN | 7 | 0.0047 |
| 3 | COSYNTROPIN | 1 | 0.0045 |
| 4 | PHENAZOPYRIDINE HYDROCHLORIDE | 1 | 0.0030 |
| 5 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 6 | BELATACEPT | 12 | 0.0025 |
| 7 | BASILIXIMAB | 24 | 0.0020 |
| 8 | ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE | 2 | 0.0020 |
| 9 | HUMAN RHO(D) IMMUNE GLOBULIN | 2 | 0.0019 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-coagulant [EPC] | 10 | 0.0027 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 15 | 0.0026 |
| 2 | Selective T Cell Costimulation Blocker [EPC] | 12 | 0.0025 |
| 3 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 4 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 5 | Human Immunoglobulin G [EPC] | 19 | 0.0009 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 16 | 0.0007 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 10 | 0.0007 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 8 | 0.0006 |
| 9 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 2 | 0.0005 |